Acquisition of Services for the Young At Heart Type 2 Diabetes Research Longitudinal Protocol
ID: 75N94024Q00265Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NICHDBETHESDA, MD, 20817, USA

NAICS

Other Scientific and Technical Consulting Services (541690)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to acquire services for the Young At Heart Type 2 Diabetes Research Longitudinal Protocol through a non-competitive purchase order to Children’s Hospital National Medical Center. This project aims to investigate the metabolic mechanisms linking metformin non-responsiveness to severe insulin resistance and cardiovascular disease risks in youth with type 2 diabetes, addressing critical health disparities in pediatric populations. The contract is set to span from September 16, 2024, to September 15, 2026, with the selected provider being the only pediatric care facility in the Washington, D.C. area, underscoring its unique capabilities in this research area. Interested vendors are encouraged to submit capability statements, and inquiries can be directed to Amber Harris at amber.harris@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH) intends to award a non-competitive purchase order to Children’s Hospital National Medical Center for the Young At Heart Type 2 Diabetes Research Longitudinal Protocol. This acquisition, categorized under NAICS code 541690 for Other Scientific and Technical Consulting Services, will span from September 16, 2024, to September 15, 2026. The project aims to investigate the metabolic mechanisms linking metformin non-responsiveness to severe insulin resistance and cardiovascular disease risks in youth with type 2 diabetes (T2D). Children’s Hospital is recognized as the only provider of pediatric care in the Washington, D.C. area, and its expertise is deemed essential for addressing diabetes disparities among diverse populations. The solicitation encourages interested parties to submit capability statements, although the Government retains discretion over proceeding non-competitively or competitively. Vendors must also comply with electronic invoicing requirements through the Invoice Processing Platform. This plan reflects a focused effort to improve T2D research outcomes for children by leveraging Children’s Hospital's unique capabilities and existing collaborative structures with NIH.
    Similar Opportunities
    A--NIH NeuroBioBank Brain and Tissue Repository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the establishment of the NIH NeuroBioBank Brain and Tissue Repository. The objective of this procurement is to create and manage contract collection sites for acquiring, storing, and distributing human brain and central nervous system tissues for research purposes, aimed at advancing the understanding of nervous system disorders. This initiative is critical for enhancing biomedical research by providing well-characterized specimens to researchers, thereby facilitating studies that could lead to improved treatments and interventions. Proposals are due by November 25, 2024, with the anticipated contract performance period starting on May 1, 2025, and extending potentially through multiple option years. Interested vendors should contact Robin D. Knightly at robin.knightly@nih.gov or call +1 301 827 5302 for further information.
    A--JHS Training and Education Centers
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the renewal of the Jackson Heart Study (JHS) Training and Education Centers. This opportunity focuses on enhancing training and educational initiatives related to heart health, particularly within the context of the JHS, which is a significant research project aimed at understanding cardiovascular disease in African American populations. The selected contractor will be responsible for providing health research and development services, contributing to applied research efforts in the field. Interested parties can reach out to Matthew Jovinelli at matthew.jovinelli@nih.gov or (301) 827-8315 for further details regarding the solicitation process.
    A--JHS Community Engagement Center
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the renewal of the Jackson Heart Study (JHS) Community Engagement Center. This procurement aims to enhance community engagement efforts related to heart health research, focusing on the development and implementation of outreach strategies that effectively involve the community in health initiatives. The services sought are critical for advancing public health research and fostering community participation in health studies. Interested parties can reach out to Matthew Jovinelli at matthew.jovinelli@nih.gov or by phone at (301) 827-8315 for further details regarding the solicitation.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    HHS ONE PROFESSIONAL SERVICES SOLUTION (HOPSS)
    Active
    Health And Human Services, Department Of
    The U.S. Department of Health and Human Services (HHS), through the National Institute on Drug Abuse (NIDA), is hosting a virtual Market Research Industry Day for the HHS One Professional Services Solution (HOPSS). This initiative aims to gather industry feedback and inform potential contractors about the professional services required to support HHS's strategic goals for 2022-2026, which focus on enhancing healthcare access, improving health outcomes, promoting social equity, and advancing scientific research. The HOPSS contract will encompass two primary task areas: STEM services and business operational support, with the anticipated contract type being a multiple award Indefinite Delivery/Indefinite Quantity (IDIQ) contract set to begin around spring or summer 2026. Interested parties must register for the event by November 15, 2024, and direct any questions to Contract Specialist Kyle Miller at kyle.miller2@nih.gov by November 13, 2024.
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Medical Insurance
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is planning to award a sole-source contract to Dr. Rhonda Robinson Beale for consulting services related to medical device development under the Blueprint MedTech Initiative. The primary objective of this procurement is to secure a subject matter expert with extensive experience in U.S. medical insurance and coverage, who will provide strategic guidance and oversight on various projects within the initiative, which aims to accelerate the development of translational neurological medical devices. The Blueprint MedTech Initiative is crucial for supporting innovators in overcoming challenges in bringing medical technologies from concept to clinical application, with a funding allocation of $32 million from 2019 to 2027 to facilitate at least ten successful clinical studies. Interested parties can reach out to Tracy Cain at tracy.cain@nih.gov or Llakim Dubroff at llakim.dubroff@nih.gov for further information, although the final decision for this contract award will remain at the government's discretion.
    Clinical Site and Study Monitoring for NIMH Funded Research in Global Settings
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for clinical site and study monitoring services for research funded by the National Institute of Mental Health (NIMH) in global settings. The primary objective of this procurement is to support efforts aimed at reducing mental health disparities, particularly in low and middle-income countries, through rigorous monitoring practices that comply with federal regulations and Good Clinical Practice. This five-year contract, expected to commence on November 25, 2024, has an anticipated budget of up to $2,000,000, with firm-fixed price task orders awarded as needed. Interested parties should direct inquiries to Cassandra Conley at cassandra.conley@nih.gov or Rieka Plugge at rieka.plugge@nih.gov.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under solicitation number 75N95024R00003. The primary objective of this procurement is to acquire, analyze, create, and distribute a variety of drug compounds essential for drug abuse and addiction research, including controlled and uncontrolled substances, while ensuring compliance with DEA regulations. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement for a five-year period, aims to enhance research capabilities in the field of drug abuse, with proposals due by November 15, 2024, at 1:00 PM (Eastern Time). Interested parties should contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov for further information.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Control (CMC) services related to the development of drug substances under RFP number 75N95024R00094. The primary objective is to secure high-quality drug substances to support preclinical and Investigational New Drug (IND)-enabling studies, ensuring compliance with current Good Manufacturing Practices (cGMP) and federal regulations. This initiative is crucial for advancing therapeutic innovations and facilitating collaborations in drug development, with a total funding amount of up to $49.7 million over the contract period from September 1, 2025, to May 14, 2031. Interested parties must submit their proposals by December 3, 2024, and can direct inquiries to primary contact Samson Shifaraw at samson.shifaraw@nih.gov or secondary contact Valerie Whipple at valerie.whipple@nih.gov.
    Preventative Maintenance Agreement for Sciex Triple Quad 6500 Systems
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to establish a Preventative Maintenance Agreement for two Sciex Triple Quad 6500 Systems utilized by the Department of Laboratory Medicine at the NIH Clinical Center. This contract aims to ensure optimal performance through annual preventative maintenance and timely repairs, which are critical for maintaining uninterrupted laboratory services for both clinical and research purposes. The selected vendor, Ab Sciex LLC, is the sole manufacturer of the equipment and will provide comprehensive coverage under the Sciex Assurance and Software Plus Plans, ensuring access to OEM parts and software support for a period from December 22, 2024, to December 21, 2027. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 8, 2024, at 6:30 AM EST, as this is not a request for proposal and the total contract value will not exceed $250,000.